Evidence map›Paper›PMID 35565785›Full record

SynthesisNutrients2022

The Effect of Non-Pharmacological and Pharmacological Interventions on Measures Associated with Sarcopenia in End-Stage Kidney Disease: A Systematic Review and Meta-Analysis.

Daniel S March, Thomas J Wilkinson, Thomas Burnell, Roseanne E Billany, Katherine Jackson, Luke A Baker, Amal Thomas, Katherine A Robinson, Emma L Watson, Matthew P M Graham-Brown and 2 more

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Daniel S MarchYork Trials Unit, Department of Health Sciences, University of York, York YO10 5DD, UK.
Thomas J WilkinsonNIHR Applied Research Collaboration, Leicester Diabetes Centre, University of Leicester, Leicester LE5 4PW, UK.
Thomas BurnellLeicester Medical School, University of Leicester, Leicester LE1 7HA, UK.
Roseanne E BillanyDepartment of Cardiovascular Sciences, University of Leicester, Leicester LE1 7RH, UK.
Katherine JacksonLeicester Medical School, University of Leicester, Leicester LE1 7HA, UK.
Luke A BakerDepartment of Respiratory Sciences, College of Life Sciences, University of Leicester, Leicester LE1 7RH, UK.ORCID 0000-0003-2111-3832
Amal ThomasUniversity Hospital of Leicester NHS Trust, Leicester LE1 5WW, UK.
Katherine A RobinsonDepartment of Cardiovascular Sciences, University of Leicester, Leicester LE1 7RH, UK.
Emma L WatsonDepartment of Cardiovascular Sciences, University of Leicester, Leicester LE1 7RH, UK.
Matthew P M Graham-BrownDepartment of Cardiovascular Sciences, University of Leicester, Leicester LE1 7RH, UK.
Arwel W JonesCentral Clinical School, Monash University, Melbourne 3004, Australia.ORCID 0000-0003-1689-8065
James O BurtonDepartment of Cardiovascular Sciences, University of Leicester, Leicester LE1 7RH, UK.
University of Leicester · GBLoughborough University · GBMonash University · AUUniversity Hospitals of Leicester NHS Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This systematic review and meta-analysis provides a synthesis of the available evidence for the effects of interventions on outcome measures associated with sarcopenia in end-stage kidney disease (ESKD). Thirteen databases were searched, supplemented with internet and hand searching. Randomised controlled trials of non-pharmacological or pharmacological interventions in adults with ESKD were eligible. Trials were restricted to those which had reported measures of sarcopenia. Primary outcome measures were hand grip strength and sit-to-stand tests. Sixty-four trials were eligible (with nineteen being included in meta-analyses). Synthesised data indicated that intradialytic exercise increased hand grip strength (standardised mean difference, 0.58; 0.24 to 0.91; p = 0.0007; I2 = 40%), and sit-to-stand (STS) 60 score (mean difference, 3.74 repetitions; 2.35 to 5.14; p < 0.001; I2 = 0%). Intradialytic exercise alone, and protein supplementation alone, resulted in no statistically significant change in STS5 (−0.78 s; −1.86 to 0.30; p = 0.16; I2 = 0%), and STS30 (MD, 0.97 repetitions; −0.16 to 2.10; p = 0.09; I2 = 0%) performance, respectively. For secondary outcomes, L-carnitine and nandrolone-decanoate resulted in significant increases in muscle quantity in the dialysis population. Intradialytic exercise modifies measures of sarcopenia in the haemodialysis population; however, the majority of trials were low in quality. There is limited evidence for efficacious interventions in the peritoneal dialysis and transplant recipient populations.

Indexed as

Kidney Failure, ChronicPeritoneal DialysisSarcopeniaAdultFemaleHand StrengthHumansMaleRenal Dialysisdialysisend-stage kidney diseaseexercisemeta-analysisnutritionsystematic reviewtransplant

Identifiers

PMID35565785
PMCPMC9101978
OpenAlexW4224981810

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.